Agenda
Applications for consideration at this meeting
- 1533 Genome-wide microarray testing for pregnancies with major foetal structual abnormalities detected by ultrasound
- 1542 Endovascular insertion of flow diversion device (FDD) for the treatment of unruptured intracranial aneurysms (UIAs)
- 1544 Genome-wide microarray testing for people with multiple myeloma and chronic lymphocytic leukaemia
- 1546 Abdominoplasty with repair of rectus diastasis (aka rectus divarication) following pregnancy
- 1551 Aspiration therapy via the insertion of a customised percutaneous endoscopic gastrostomy tube into the stomach for weight loss management in obese patients with a BMI ≥ 35
- 1552 Transcatheter Aortic Valve Implantation (TAVI) via Transfemoral Delivery for Patients at Intermediate Risk for Surgery
- 1553 Transmural fixation of aortic endograft adjunct to endovascular aneurysm repair using helical anchors
- 1554 Testing of tumour tissue or blood to detect somatic or germline BRCA1 or BRCA2 gene mutations, in a patient with newly diagnosed, advanced (FIGO stage III-IV) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to first-line platinum-based chemotherapy)
- 1555 Endoscopic Sleeve Gastroplasty (ESG) for the treatment of patients with Class I and Class II obesity with comorbidities who have failed first-line treatments
- 1556 Human tissue (topical) wound treatments – Ulcers and burns (EpiFix and EpiBurn)
- 1557 Human tissue (surgical) wound treatments – Laminectomy and tendon repair (AmnioFix, AmnioWrap and AmnioFix Injectable)
- 1562 Streamlining Medicare Benefits Schedule Items for Positron Emission Tomography (PET) Project
Related information
Committee: